Breaking News

Avacta Relocates Therapeutics Division to Scale Space, Imperial College White City Campus

Brings its Therapeutics research and development teams together in a single space to accelerate its therapeutic programs into the clinic.

Author Image

By: Charlie Sternberg

Associate Editor

Avacta Group plc, a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION and Affimer platforms, has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.   The new headquarters, which will see Avacta be part of a life science cluster at the west London site, brings together its research and development teams to support the continued growth of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters